InMed Pharmaceuticals (FRA:MWG) Beginning Cash Position : €5.33 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Beginning Cash Position?

InMed Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2024 was €5.33 Mil.

InMed Pharmaceuticals's quarterly Beginning Cash Position declined from Jun. 2024 (€7.06 Mil) to Sep. 2024 (€5.92 Mil) and declined from Sep. 2024 (€5.92 Mil) to Dec. 2024 (€5.33 Mil).

InMed Pharmaceuticals's annual Beginning Cash Position declined from Jun. 2022 (€6.97 Mil) to Jun. 2023 (€5.70 Mil) but then increased from Jun. 2023 (€5.70 Mil) to Jun. 2024 (€8.28 Mil).

InMed Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for InMed Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Beginning Cash Position Chart

InMed Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

Get a 7-Day Free Trial

8.74

4.82

6.97

5.70

8.28

InMed Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															6.18	8.77	7.06	5.92	5.33

InMed Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

InMed Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InMed Pharmaceuticals Inc (FRA:MWG) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

INM:USA MWG:Germany

Address

885 West Georgia Street, Suite 1445, Vancouver, BC, CAN, V6C 3E8

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.